Global ovarian cancer drugs market is growing significantly at a CAGR of 13.8%, during the forecast period. Ovarian cancer drugs are being widely used in combination with chemotherapy for the treatment of ovarian cancer that contributes to the growth of the market. Chemotherapy, after surgery, is recommended for most cases of ovarian cancer, as it kills cancerous cells. In some cases, chemotherapy may be recommended before surgery. Albumin-bound paclitaxel, Altretamine, Capecitabine, Cyclophosphamide, and others are the chemotherapy drugs that are used in the treatment of ovarian cancer. These chemotherapy drugs offer substantial opportunity in the treatment of the ovarian cancer; thus, contributing significantly in the growth of the market.


(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/ovarian-cancer-drugs-market-size

Global ovarian cancer drugs market is growing significantly at a CAGR of 13.8%, during the forecast period. The market is backed by the growing adoption of novel drugs and strong pipeline products. Increasing incidences of ovarian cancer across the globe is one of the major factors that contribute to the growth of the market. According to the World Cancer Research Fund (WCRF), ovarian cancer is the eighth most commonly occurring cancer in women and the 18th most common type in all cancer. There were around 300,000 new cases in 2018. Moreover, rising healthcare expenditure is allowing a large number of people to access advanced healthcare facilities, which in turn, is contributing to the diagnosis and treatment of various cancers, including ovarian cancer.


A Full Report of Global Global Ovarian Cancer Drugs Market is Available at: https://www.omrglobal.com/industry-reports/ovarian-cancer-drugs-market-size

Market Segmentation
Global Ovarian Cancer Drugs Market by Drug Class
 PARP Inhibitors
 Angiogenesis Inhibitors
 PD-L1 Inhibitors

Global Ovarian Cancer Drugs Market by Therapy
 Chemotherapy
 Targeted Therapy
 Immuno therapy
 Others (Hormonal Therapy)

Company Profiles

 Amgen Inc.
 AbbVie Inc.
 Astra Zeneca PLC
 Boehringer Ingelheim GmbH
 Bristol-Myers Squibb Co.
 Clovis Oncology, Inc.
 DelMar Pharmaceuticals, Inc.
 Eli Lilly and Co.
 Exelixis, Inc.
 F. Hoffmann-La Roche Ltd.
 Genentech, Inc.
 GlaxoSmithKline PLC
 ImmunoGen Inc.
 Janssen Global Services, LLC, a division of Johnson & Johnson Services, Inc,
 Merck & Co., Inc.
 Mersana Therapeutics, Inc.
 Oasmia Pharmaceutical AB
 7.18. Once Bio Mune Pharmaceuticals Inc.
 Pfizer Inc.


Global Ovarian Cancer Drugs Market – Segmentation by Region

North America

• United States
• Canada


Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe


Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific


Rest of the World

• Middle East & Africa
• Latin America


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ovarian-cancer-drugs-market-size

Reasons to Buying From us –
• We cover more than 15 major industries, further segmented into more than 90 sectors.
• More than 120 countries are for analysis.
• Over 100+ paid data sources mined for investigation.
• Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404